|
| |
Image Results
Loading...
Loading...
CAFERGOT Pages on BioPortfolio:
Biotechnology News CAFERGOT Search
Biotechnology and Pharmaceutical Industry Search Find Companies, News, Events, Jobs, Directory.
http://www.bioportfolio.co.uk/CAFERGOT-news.htm...
|
BioPortfolio - Cafergot
Press Releases About Cafergot: BioPortfolio Logo. Abbott Study Shows Investigational Heat-Stable Norvir(R) Tablet Provides Similar Drug Levels to
Current ...
http://www.bioportfolio.com/indepth/Cafergot.html...
|
BioPortfolio.com - BioWeb ARTHROTEC DICLOFENAC MISOPROSTOL ...
1 g, cadraten 30 cpr 10 mg, cadraten 30 cpr 15 mg, caelyx iv 1 fl 2 mg ml, cafergot 20 cpr, cafergot 5 sup., caffalgina 12 conf., caffalgina os 6 flac.ni,
...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?DB=se...
|
Results from other life science and pharmaceutical sites:
Cafergot - Wikipedia, the free encyclopedia
Cafergot is the proprietary name of a medication consisting of ergotamine tartrate and caffeine. This combination is used for the treatment of vascular
...
http://en.wikipedia.org/wiki/Cafergot...
|
Cafergot (ergotamine tartrate and caffeine)
7 Jul 2009 ... Serious and/or life-threatening peripheral ischemia has been associated with the coadministration of Cafergot with potent CYP 3A4 inhibitors ...
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyA...
|
cafergot (ergotamine tartrate and caffeine) suppository [Novartis ...
Serious and/or life-threatening peripheral ischemia has been associated with the coadministration of CAFERGOT® (ergotamine tartrate and caffeine) with ...
http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=1862...
|
Cafergot (ergotamine tartrate and caffeine) Dear Healthcare ...
7 Jul 2009 ... Cafergot (ergotamine tartrate and caffeine) Dear Healthcare Professional Letter Oct 2002.
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyA...
|
Efficacy, tolerability and safety of oral eletriptan and ...
The efficacy, tolerability and safety of 40- and 80-mg doses of eletriptan and 2 tablets of Cafergot were compared in a double-blind, randomised, ...
http://www.ncbi.nlm.nih.gov/pubmed/11844898...
|
Cafergot Plus CYP 3A4 Inhibitor Linked With Fatal Ischemia
14 Nov 2002 ... Because CYP 3A4 inhibition elevates the drug serum levels, which increases risk of vasospasm, concomitant use of these medications is ...
http://www.medscape.com/viewarticle/444645...
|
CAFERGOT®
the coadministration of CAFERGOT® with potent CYP 3A4 inhibitors ... of CAFERGOT ®, the risk for vasospasm leading to cerebral ischemia and/or ischemia of ...
http://www.pharma.us.novartis.com/product/pi/pdf/Cafergot_ta...
|
Symptomatic relief of migraine: multicenter comparison of Cafergot ...
A multicenter, randomized, double-blind trial was conducted to compare the efficacy of Cafergot P-B with that of its components, Cafergot, pentobarbital,
...
http://www.ncbi.nlm.nih.gov/pubmed/2497984...
|
CAFERGOT
CYP 3A4 inhibition elevates the serum levels of CAFERGOT, the risk for vasospasm ... CAFERGOT suppositories are sealed in foil to afford protection from ...
http://www.pharma.us.novartis.com/product/pi/pdf/cafergot.pd...
|
A randomized, double-blind comparison of sumatriptan and Cafergot ...
The efficacy and safety of oral sumatriptan as a 100-mg dispersible tablet was compared with oral Cafergot (2 mg ergotamine tartrate, 200 mg caffeine) in a ...
http://www.ncbi.nlm.nih.gov/pubmed/1653139...
|
|
